ADMA Biologics (ADMA) News Today $15.84 -0.24 (-1.49%) Closing price 04:00 PM EasternExtended Trading$15.88 +0.04 (+0.22%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period 33,000 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 33,000 shares of the biotechnolFebruary 20 at 4:19 AM | marketbeat.comVan ECK Associates Corp Invests $3.42 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Van ECK Associates Corp purchased a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 199,630 shares of the biotechnology company's stock, valFebruary 20 at 3:16 AM | marketbeat.comADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards?February 19 at 2:05 PM | msn.comADMA Biologics (ADMA) to Release Quarterly Earnings on WednesdayADMA Biologics (NASDAQ:ADMA) will be releasing earnings before the market opens on Wednesday, February 26.February 19 at 3:54 AM | marketbeat.comNkcfo LLC Invests $325,000 in ADMA Biologics, Inc. (NASDAQ:ADMA)Nkcfo LLC purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 18,950 shares of the biotechnology company's stock, vFebruary 16, 2025 | marketbeat.comLegato Capital Management LLC Sells 17,347 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Legato Capital Management LLC decreased its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 28.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,285 shares of the biotechnology company's stock afteFebruary 14, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Buys 2,613,482 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Allspring Global Investments Holdings LLC boosted its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 1,144.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,841,849 shares of the biotechnoloFebruary 14, 2025 | marketbeat.comSG Americas Securities LLC Sells 37,638 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)SG Americas Securities LLC cut its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 85.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,554 shares of the biotechnology company's stockFebruary 13, 2025 | marketbeat.comAdma Biologics (ADMA) Stock Moves -0.25%: What You Should KnowFebruary 13, 2025 | msn.comEmpowered Funds LLC Invests $5.68 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Empowered Funds LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 331,209 shares of the biotechnology company's stock, valued at appFebruary 12, 2025 | marketbeat.comADMA Biologics: Recent Pullback Is A Perfect Opportunity To AddFebruary 6, 2025 | seekingalpha.comCalamos Advisors LLC Raises Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Calamos Advisors LLC boosted its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 425,906 shares of the biotechnology companyFebruary 5, 2025 | marketbeat.comEngaging In Insider Activity, Kaitlin M. Kestenberg-Messina At ADMA Biologics Exercises Options Worth $28KFebruary 4, 2025 | benzinga.comADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Up 11.8% in JanuaryADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 13,620,000 shares, an increase of 11.8% from the December 31st total of 12,180,000 shares. Based on an average daily volume of 3,500,000 shares, the days-to-cover ratio is currently 3.9 days.February 1, 2025 | marketbeat.comJim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’January 30, 2025 | insidermonkey.comLightning Round: You should own and buy Keysight, says Jim CramerJanuary 30, 2025 | msn.comInspire Investing LLC Sells 41,176 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Inspire Investing LLC reduced its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 63.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,491 shares of tJanuary 26, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Position Raised by Veracity Capital LLCVeracity Capital LLC raised its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 117.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,415 shares of the biotechnology company's stock after purJanuary 24, 2025 | marketbeat.comMizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT)January 23, 2025 | markets.businessinsider.comCantor Fitzgerald Weighs in on ADMA Biologics FY2025 EarningsADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share estimates for ADMA Biologics in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company wilJanuary 22, 2025 | marketbeat.comPerpetual Ltd Invests $62.30 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Perpetual Ltd purchased a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,632,677 shares of the biotechnology cJanuary 21, 2025 | marketbeat.comThere May Still Be Time to Get in on These 3 Trending Biotechs (ADMA)Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.January 20, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 2,882,776 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Assenagon Asset Management S.A. trimmed its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 83.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 591,679 shares of the biotechJanuary 19, 2025 | marketbeat.comADMA Biologics Inc. (ADMA): Why Should You Buy This Growth Stock For The Next 5 Years?January 18, 2025 | msn.comADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest UpdateADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 13,620,000 shares, an increase of 11.8% from the December 15th total of 12,180,000 shares. Based on an average daily trading volume, of 3,500,000 shares, the days-to-cover ratio is currently 3.9 days.January 18, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. reduced its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 14.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 205,955 shares of the biotechnology company's stoJanuary 18, 2025 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Down 8.8% - Here's WhyADMA Biologics (NASDAQ:ADMA) Trading Down 8.8% - Here's What HappenedJanuary 15, 2025 | marketbeat.comFY2024 EPS Estimates for ADMA Biologics Raised by AnalystADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) - Investment analysts at Cantor Fitzgerald raised their FY2024 earnings estimates for ADMA Biologics in a research note issued on Tuesday, January 14th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post eaJanuary 15, 2025 | marketbeat.comAdma Biologics reports preliminary FY24 revenue $417M-$425M, consensus $423.19MJanuary 14, 2025 | markets.businessinsider.comADMA Biologics Raises Full-year Revenue OutlookJanuary 13, 2025 | markets.businessinsider.comADMA Biologics (NASDAQ:ADMA) Trading Down 8.8% - What's Next?ADMA Biologics (NASDAQ:ADMA) Shares Down 8.8% - Time to Sell?January 13, 2025 | marketbeat.comEWG Elevate Inc. Makes New $480,000 Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)EWG Elevate Inc. bought a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 28,000 shares of the biotechnology company'sJanuary 13, 2025 | marketbeat.comADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business UpdateJanuary 13, 2025 | markets.businessinsider.comIs ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25?January 9, 2025 | insidermonkey.comHow Is The Market Feeling About ADMA Biologics?January 1, 2025 | benzinga.comWhy Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now?January 1, 2025 | msn.comTop 5 best performing small-cap US stocks in 2024December 30, 2024 | msn.comStocks Showing Rising Market Leadership: Arcellx Earns 82 RS RatingDecember 27, 2024 | msn.comPrincipal Financial Group Inc. Acquires 1,059,394 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Principal Financial Group Inc. raised its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 785.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,194,221 shares of the biotechnology company's stock after buying an additiDecember 26, 2024 | marketbeat.comCarillon Chartwell Small Cap Growth Fund Q3 2024 CommentaryDecember 25, 2024 | seekingalpha.comTidal Investments LLC Lowers Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Tidal Investments LLC decreased its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 46.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,334 shares of the biotechnology company's stock aDecember 21, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Here's WhyADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Should You Sell?December 20, 2024 | marketbeat.comADMA Biologics Announces Partial Paydown of Senior Term Loan Credit FacilityDecember 20, 2024 | globenewswire.comTeachers Retirement System of The State of Kentucky Invests $1.05 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Teachers Retirement System of The State of Kentucky acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 52,392 shares of the biotechnology company'December 19, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 2.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,381,985 shares of the biotechnology company's stock after purchasing an additionalDecember 19, 2024 | marketbeat.comWellington Management Group LLP Reduces Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Wellington Management Group LLP trimmed its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 80.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,293 shares of the biotechnology company's sDecember 18, 2024 | marketbeat.comApogee Therapeutics Trying To Close In On Key Technical MeasureDecember 17, 2024 | msn.comBarclays PLC Acquires 347,692 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Barclays PLC lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 192.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 528,629 shares of the biotechnology company's stock after acquiring an additioDecember 17, 2024 | marketbeat.comLord Abbett & CO. LLC Invests $61.86 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Lord Abbett & CO. LLC purchased a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,094,457 shares of the biotechnology company's stock,December 15, 2024 | marketbeat.comNeo Ivy Capital Management Purchases Shares of 48,584 ADMA Biologics, Inc. (NASDAQ:ADMA)Neo Ivy Capital Management acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 48,584 shares of the biotechnology comDecember 12, 2024 | marketbeat.com Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMA Media Mentions By Week ADMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼0.940.60▲Average Medical News Sentiment ADMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼57▲ADMA Articles Average Week Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GMAB News ITCI News VTRS News MRNA News RDY News PCVX News SRPT News QGEN News ASND News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADMA Stock Alerts